Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso‐occlusion and nephropathy in mouse models of sickle cell disease is a research paper published in British Journal of Pharmacology (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: FOR 2060 projects FE 438/5‐2 and FE 438/6‐2
Deutsche Forschungsgemeinschaft
Grant: Projektnummer 374031971 ‐ TRR 240
National Institutes of Health
Grant: 1F32HL142243
National Institutes of Health
Grant: R01 HL069438
NIDDK NIH HHS
Grant: R01 DK056638
NHLBI NIH HHS
Grant: F32 HL142243
FWCI
2.06
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals